|
GNL3L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.5590202420226E-14 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.12085904394144E-12 |
| Normal-vs-Stage2 |
3.24760218717302E-11 |
| Normal-vs-Stage3 |
2.99760216648792E-14 |
| Normal-vs-Stage4 |
1.62458935193399E-12 |
| Stage1-vs-Stage2 |
9.524800E-01 |
| Stage1-vs-Stage3 |
1.803630E-01 |
| Stage1-vs-Stage4 |
6.979100E-04 |
| Stage2-vs-Stage3 |
3.167400E-01 |
| Stage2-vs-Stage4 |
2.008000E-02 |
| Stage3-vs-Stage4 |
9.432300E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.63753513158372E-14 |
| Normal-vs-AfricanAmerican |
1.492799999947E-06 |
| Normal-vs-Asian |
3.55604434787438E-13 |
| Caucasian-vs-AfricanAmerican |
2.385600E-01 |
| Caucasian-vs-Asian |
7.147200E-01 |
| AfricanAmerican-vs-Asian |
1.731240E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.74504855010582E-12 |
| Normal-vs-Female |
1.23456800338317E-13 |
| Male-vs-Female |
7.508600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.31192842647943E-12 |
| Normal-vs-Age(41-60Yrs) |
1.67577063336921E-12 |
| Normal-vs-Age(61-80Yrs) |
7.84927678409986E-14 |
| Normal-vs-Age(81-100Yrs) |
6.395200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.205200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.647200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.924400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.399800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.537000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.273600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.447930E-02 |
| Classical-VS-Follicular |
3.016000E-01 |
| Classical-VS-Other |
2.683400E-01 |
| Classical-VS-Normal |
4.21318535615001E-12 |
| Tall-VS-Follicular |
8.808100E-02 |
| Tall-VS-Other |
8.788800E-01 |
| Tall-VS-Normal |
2.1538326677728E-14 |
| Follicular-VS-Other |
5.224200E-01 |
| Follicular-VS-Normal |
1.24122934153093E-12 |
| Other-VS-Normal |
1.571470E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.78468351208494E-12 |
| Normal-vs-N1 |
1.62470037423645E-12 |
| N0-vs-N1 |
7.502600E-03 |
|
|
